Bachem Holding AG
Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commerci… Read more
Bachem Holding AG (BCHMF) - Total Liabilities
Latest total liabilities as of June 2025: $550.82 Million USD
Based on the latest financial reports, Bachem Holding AG (BCHMF) has total liabilities worth $550.82 Million USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Bachem Holding AG - Total Liabilities Trend (2002–2024)
This chart illustrates how Bachem Holding AG's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Bachem Holding AG Competitors by Total Liabilities
The table below lists competitors of Bachem Holding AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Western Metal Materials Co Ltd
SHE:002149
|
China | CN¥3.80 Billion |
|
Summit Therapeutics PLC
NASDAQ:SMMT
|
USA | $69.47 Million |
|
The Baldwin Insurance Group, Inc.
NASDAQ:BWIN
|
USA | $2.78 Billion |
|
Hengan International Group Company Limited
F:HGNC
|
Germany | €20.54 Billion |
|
Harley-Davidson Inc
NYSE:HOG
|
USA | $4.89 Billion |
|
Indian Railway Finance Corporation Limited
NSE:IRFC
|
India | ₹4.42 Trillion |
Liability Composition Analysis (2002–2024)
This chart breaks down Bachem Holding AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.44 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.41 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.29 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bachem Holding AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bachem Holding AG (2002–2024)
The table below shows the annual total liabilities of Bachem Holding AG from 2002 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $531.88 Million | +46.78% |
| 2023-12-31 | $362.36 Million | +69.16% |
| 2022-12-31 | $214.21 Million | +20.68% |
| 2021-12-31 | $177.50 Million | -24.52% |
| 2020-12-31 | $235.17 Million | +17.98% |
| 2019-12-31 | $199.33 Million | -13.52% |
| 2018-12-31 | $230.49 Million | +35.20% |
| 2017-12-31 | $170.48 Million | +30.00% |
| 2016-12-31 | $131.15 Million | +44.96% |
| 2015-12-31 | $90.47 Million | +5.34% |
| 2014-12-31 | $85.88 Million | -16.08% |
| 2013-12-31 | $102.34 Million | -20.35% |
| 2012-12-31 | $128.49 Million | +1.92% |
| 2011-12-31 | $126.06 Million | +26.56% |
| 2010-12-31 | $99.60 Million | +1.30% |
| 2009-12-31 | $98.33 Million | +19.67% |
| 2008-12-31 | $82.16 Million | +17.90% |
| 2007-12-31 | $69.69 Million | +31.44% |
| 2006-12-31 | $53.02 Million | +39.59% |
| 2005-12-31 | $37.98 Million | +0.22% |
| 2004-12-31 | $37.90 Million | +18.82% |
| 2003-12-31 | $31.90 Million | -4.01% |
| 2002-12-31 | $33.23 Million | -- |